US 8962530
Inflammatory bowel disease therapies
granted A61KA61K31/47A61K31/473
Quick answer
US patent 8962530 (Inflammatory bowel disease therapies) held by The Regents of the University of Colorado expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/47, A61K31/473, A61K31/7088, A61P